Leerink Partners Initiates Coverage On Immunocore Hldgs with Outperform Rating, Announces Price Target of $74
Portfolio Pulse from Benzinga Newsdesk
Leerink Partners analyst Jonathan Chang initiates coverage on Immunocore Hldgs (NASDAQ:IMCR) with an Outperform rating and a price target of $74.
April 29, 2024 | 1:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Leerink Partners initiated coverage on Immunocore Holdings with an Outperform rating and set a price target of $74.
The initiation of coverage by Leerink Partners with an Outperform rating and a high price target suggests a positive outlook for Immunocore Holdings. This endorsement from a reputable analyst could lead to increased investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100